Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	52.90	-26.82	-56.94
Graham Fair Price	41.42	2.81	1.98
PEG	-97.83	< 0.005	0.24
Price/Book	31.25	-0.10	-0.14
Price/Cash Flow	31.25	-124.64	-181.30
Prices/Earnings	65.63	-0.54	-1.58
Price/Sales	-65.63	7.77	22.60
Price/FCF	31.25	-124.64	-181.30
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.55	0.55
Operating Margin	1.88	-1.34	-1.36
ROA	-100.00	-0.70	-0.35
ROE	0.02	0.05	100.00
ROIC	0.01	0.03	96.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-90.93
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.50	-0.96	92.73
EPS QOQ	0.07	-1.05	1487.59
FCF QOQ	0.13	0.00	inf
Revenue QOQ	-0.49	1.00	102.09
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-71.79	-100.00
Days Sales Outstanding (DSO)	477.12	270.93	-43.21
Inventory Turnover	0.00	-1.25	-100.00
Debt/Capitalization	-0.54	-0.54	-0.13
Quick Ratio	0.04	0.05	12.35
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	-2.76	-2.76	< 0.005
Cash	< 0.005	< 0.005	< 0.005
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	< 0.005
Revenue	0.02	0.04	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.08	0.05	-33.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-40.25	-20.87	48.14
Naive Interpretation	Member

06 - Financial Health · Bad

Rating